A new wave in regenerative medicine is the shift from tissue grafts or transplants, to engineering the cells to produce specific therapeutic secretions.
This stimulates tissue healing from within, reducing body rejection risk and opening the doorway for a different approach towards healing, from physical injury to neurodegenerative disease.
Could this start a war between Genetic engineering and Regenerative Medicine disciplines?
Or could this be the very necessary marriage of fields we need to move further?
Share your thoughts.
This strategy appears to make use of the body’s own biochemical vocabulary to coach the healing tissue instead of simply moving cells. It could symbolise an innovative concept that brings together the best aspects of genetic manipulation with regenerative medicine’s aims.
This shift from cell transplants to harnessing cellular secretions is fascinating it highlights how regenerative medicine is moving from replacement to modulation.
By leveraging the paracrine effects of engineered cells, we can stimulate tissue repair internally while minimizing immune rejection.
Rather than a ‘war’ between genetic engineering and regenerative medicine, this seems like a powerful synergy: genetic tools enable precise control over secretions, while regenerative approaches focus on functional healing.
The integration of both could truly redefine how we approach tissue repair and neurodegenerative therapies.